ProfileGDS4459 / ENSG00000175662
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 28% 43% 40% 24% 39% 44% 39% 34% 39% 35% 34% 40% 45% 42% 40% 39% 49% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.6928
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.1943
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.9740
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.6324
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.9739
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.1844
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.9639
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.7434
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.9339
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.8235
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.7534
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.9440
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.2345
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.1642
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.9640
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.0739
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.3649